Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation

Description

The purpose of this study is to determine the preliminary efficacy (via a micro-randomized trial \[MRT\] design) of augmenting Enhanced-Replicating Effective Program (E-REP) with engagement strategies to increase and sustain reach by healthcare providers (e.g., nurses, social workers) during implementation of the SafERteens program across multiple healthcare settings.

Conditions

Violence in Adolescence

Study Overview

Study Details

Study overview

The purpose of this study is to determine the preliminary efficacy (via a micro-randomized trial \[MRT\] design) of augmenting Enhanced-Replicating Effective Program (E-REP) with engagement strategies to increase and sustain reach by healthcare providers (e.g., nurses, social workers) during implementation of the SafERteens program across multiple healthcare settings.

Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation

Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation

Condition
Violence in Adolescence
Intervention / Treatment

-

Contacts and Locations

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48109

Fruitport

Trinity Health Medical Group, Academic Family Medicine - Fruitport, Fruitport, Michigan, United States, 49415

Grand Rapids

Helen DeVos Children's Hospital Emergency Department, Grand Rapids, Michigan, United States, 49503

Muskegon

Muskegon Pediatrics, Muskegon, Michigan, United States, 49440

Muskegon

HealthWest Youth and Family Services, Muskegon, Michigan, United States, 49442

Muskegon

Hackley Community Care Medical Services, Muskegon, Michigan, United States, 49444

Muskegon

Trinity Health-Emergency Department, Muskegon, Michigan, United States, 49444

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Employed at study site
  • * Participate in screening and/or SafERteens delivery.
  • * Would not be expected to complete screening and/or intervention delivery
  • * Would not begin screening and/or delivering SafERteens within the first 9 months of cohort implementation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Michigan,

Patrick Carter, MD, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

2027-12